-
1.
公开(公告)号:US20210309725A1
公开(公告)日:2021-10-07
申请号:US16860239
申请日:2020-04-28
Applicant: H. Lundbeck A/S
Inventor: Roger K. Cady , Jeffrey T.L. Smith , Joseph Hirman
Abstract: Methods for treatment of most bothersome symptom (MBS) associated with migraine are provided. Exemplary methods provide improvement in MBS associated with migraine within 1 month of administration og anti-CGRP antibodies of the invention. Also provided are methods for improvement of patient impression of change (PGIC) associated with migraine. Exemplary methods comprise administration of an anti-CGRP antagonistic antibody to a patient in need thereof.
-
公开(公告)号:US12215144B2
公开(公告)日:2025-02-04
申请号:US18609223
申请日:2024-03-19
Applicant: H. LUNDBECK A/S
Inventor: Roger K. Cady , Jeffrey T.L. Smith , Joseph Hirman , Barbara Schaeffler , Lahar Mehta
IPC: C07K16/18 , A61K9/00 , A61K31/4172 , A61K38/00 , A61K39/00 , A61K39/395 , A61K45/06 , A61K47/26 , A61P25/06
Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
-
公开(公告)号:US20240270832A1
公开(公告)日:2024-08-15
申请号:US18609223
申请日:2024-03-19
Applicant: H. LUNDBECK A/S
Inventor: Roger K. Cady , Jeffrey T.L. Smith , Joseph Hirman , Barbara Schaeffler , Lahar Mehta
IPC: C07K16/18 , A61K9/00 , A61K31/4172 , A61K38/00 , A61K39/00 , A61K39/395 , A61K45/06 , A61K47/26 , A61P25/06
CPC classification number: C07K16/18 , A61K9/0019 , A61K31/4172 , A61K39/3955 , A61K45/06 , A61K47/26 , A61P25/06 , A61K38/00 , A61K2039/505 , A61K2039/545 , C07K2317/24
Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
-
公开(公告)号:US20240239880A1
公开(公告)日:2024-07-18
申请号:US18609247
申请日:2024-03-19
Applicant: H. LUNDBECK A/S
Inventor: Roger K. Cady , Jeffrey T.L. Smith , Joseph Hirman , Barbara Schaeffler , Lahar Mehta
IPC: C07K16/18 , A61K9/00 , A61K31/4172 , A61K39/395 , A61K45/06 , A61K47/26 , A61P25/06 , A61K38/00 , A61K39/00
CPC classification number: C07K16/18 , A61K9/0019 , A61K31/4172 , A61K39/3955 , A61K45/06 , A61K47/26 , A61P25/06 , A61K38/00 , A61K2039/505 , A61K2039/545 , C07K2317/24
Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
-
公开(公告)号:US20240067708A1
公开(公告)日:2024-02-29
申请号:US18173124
申请日:2023-02-23
Applicant: H. Lundbeck A/S
Inventor: Roger K. Cady , Jeffrey T.L. Smith , Joseph Hirman , Barbara Schaeffler , Lahar Mehta
IPC: C07K16/18 , A61K9/00 , A61K31/4172 , A61K39/395 , A61K45/06 , A61K47/26 , A61P25/06
CPC classification number: C07K16/18 , A61K9/0019 , A61K31/4172 , A61K39/3955 , A61K45/06 , A61K47/26 , A61P25/06 , A61K2039/505
Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
-
公开(公告)号:US11639380B2
公开(公告)日:2023-05-02
申请号:US16736925
申请日:2020-01-08
Applicant: H. LUNDBECK A/S
Inventor: Roger K. Cady , Jeffrey T. L. Smith , Joseph Hirman , Barbara Schaeffler , Lahar Mehta
IPC: C07K16/18 , A61K9/00 , A61K39/395 , A61K31/4172 , A61K47/26 , A61K38/00 , A61P25/06 , A61K45/06 , A61K39/00
Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
-
公开(公告)号:US12215145B2
公开(公告)日:2025-02-04
申请号:US18609247
申请日:2024-03-19
Applicant: H. LUNDBECK A/S
Inventor: Roger K. Cady , Jeffrey T. L. Smith , Joseph Hirman , Barbara Schaeffler , Lahar Mehta
IPC: C07K16/18 , A61K9/00 , A61K31/4172 , A61K38/00 , A61K39/00 , A61K39/395 , A61K45/06 , A61K47/26 , A61P25/06
Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
-
公开(公告)号:US20240343784A1
公开(公告)日:2024-10-17
申请号:US18511241
申请日:2023-11-16
Applicant: H. Lundbeck A/S
Inventor: Roger K. Cady , Jeffrey T.L. Smith , Joseph Hirman , Barbara Schaeffler , Lahar Mehta
CPC classification number: C07K16/18 , A61K47/10 , A61K47/183 , A61K47/34 , A61P25/06 , A61K2039/505 , A61K2039/545 , C07K2317/20 , C07K2317/41 , C07K2317/565
Abstract: Methods for treatment or prevention of medication overuse headache are provided. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
-
9.
公开(公告)号:US20240101653A1
公开(公告)日:2024-03-28
申请号:US18182822
申请日:2023-03-13
Applicant: H. Lundbeck A/S
Inventor: Roger K. Cady , Jeffrey T.L. Smith , Joseph Hirman
CPC classification number: C07K16/18 , A61K9/0019 , A61P25/06 , A61K2039/545
Abstract: Methods for treatment of most bothersome symptom (MBS) associated with migraine are provided. Exemplary methods provide improvement in MBS associated with migraine within 1 month of administration og anti-CGRP antibodies of the invention. Also provided are methods for improvement of patient impression of change (PGIC) associated with migraine. Exemplary methods comprise administration of an anti-CGRP antagonistic antibody to a patient in need thereof.
-
公开(公告)号:US20240076359A1
公开(公告)日:2024-03-07
申请号:US18173116
申请日:2023-02-23
Applicant: H. Lundbeck A/S
Inventor: Roger K. Cady , Jeffrey T.L. Smith , Joseph Hirman , Barbara Schaeffler , Lahar Mehta
IPC: C07K16/18 , A61K9/00 , A61K31/4172 , A61K39/395 , A61K45/06 , A61K47/26 , A61P25/06
CPC classification number: C07K16/18 , A61K9/0019 , A61K31/4172 , A61K39/3955 , A61K45/06 , A61K47/26 , A61P25/06 , A61K2039/505
Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
-
-
-
-
-
-
-
-
-